Skip to main content
Dash Bio, Inc.DB
SEC Form D filing

Dash Bio, Inc.

Biotech · Series B · Regulation D 506(b) · MA · Filed July 14, 2026

Offering amount
$30.0M
Exemption
Reg D 506(b)
Issuer state
MA
Filing date
July 14, 2026
Signature date
July 14, 2026
CIK
0002041370

What is a Form D filing?

A Form D is the notice a private company files with the U.S. Securities and Exchange Commission when raising capital through an offering exempt under Regulation D (Rule 506(b), 506(c), or 504). It discloses the offering but is not a solicitation, an endorsement, or a statement of investment merit. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Public filing directories

Browse directories that group public SEC Form D records by the same filing tags shown on this page. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Summary

Auto-generated

The issuer's name clearly indicates a biotechnology focus. The $30,000,022 offering amount suggests a Series B stage. Form D reports a $30.0M Reg D 506(b) offering from MA, and the issuer name and filed fields support the biotech/series-b classification.

Generated automatically by a language model from the public SEC filing; may contain errors. Verify against the source document on EDGAR. FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.

Source

FormDFlow surfaces public-disclosure data from SEC EDGAR. Nothing here is investment advice.